Loading...
Market
HMPV vaccine approved for use in China by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Chinese health authorities or international health organizations
Story
China Faces HMPV Surge; Hospitals Reportedly Overwhelmed
Jan 3, 2025, 11:23 AM
China is reportedly facing a surge in respiratory illnesses attributed to the human metapneumovirus (HMPV), five years after the COVID-19 pandemic. Reports suggest that hospitals in several parts of the country are overwhelmed due to the rapid spread of HMPV, which causes flu-like and COVID-19-like symptoms. The virus affects children and the elderly most and typically spreads during winter months. China is piloting a monitoring system for pneumonia of unknown origin. Experts emphasize that HMPV is a known virus that triggers a rise in respiratory illnesses every winter.
View original story
Similar markets
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Contained • 25%
Worsening • 25%
Stable • 25%
Resolved • 25%
Social distancing • 25%
Other • 25%
Face masks • 25%
Hand washing • 25%